Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text PDF (Full Text) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Google Scholar Articles by Wang, J. Articles by Li, X.-J. PubMed PubMed Citation Articles by Wang, J. Articles by Li, X.-J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Huntington's Disease Social Bookmarking                      What's this?

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322

Correspondence to Xiao-Jiang Li: xiaoli{at}genetics.emory.edu

Huntington's disease (HD) is caused by the expansion of a polyglutamine tract in the N-terminal region of huntingtin (htt) and is characterized by selective neurodegeneration. In addition to forming nuclear aggregates, mutant htt accumulates in neuronal processes as well as synapses and affects synaptic function. However, the mechanism for the synaptic toxicity of mutant htt remains to be investigated. We targeted fluorescent reporters for the ubiquitin–proteasome system (UPS) to presynaptic or postsynaptic terminals of neurons. Using these reporters and biochemical assays of isolated synaptosomes, we found that mutant htt decreases synaptic UPS activity in cultured neurons and in HD mouse brains that express N-terminal or full-length mutant htt. Given that the UPS is a key regulator of synaptic plasticity and function, our findings offer insight into the selective neuronal dysfunction seen in HD and also establish a method to measure synaptic UPS activity in other neurological disease models.

Abbreviations used in this paper: HD, Huntington's disease; htt, huntingtin; polyQ, polyglutamine; PSD, postsynaptic density; RFP, DsRed fusion protein; SDH, succinate dehydrogenase; UPS, ubiquitin–proteasome system.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Wang, C.-E., Tydlacka, S., Orr, A. L., Yang, S.-H., Graham, R. K., Hayden, M. R., Li, S., Chan, A. W.S., Li, X.-J. (2008). Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. Hum Mol Genet 17: 2738-2751 [Abstract] [Full Text]  
• Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., Mee, M., Soane, T., Layfield, R., Sheppard, P. W., Ebendal, T., Usoskin, D., Lowe, J., Mayer, R. J. (2008). Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies. J. Neurosci. 28: 8189-8198 [Abstract] [Full Text]  
• Orr, A. L., Huang, S., Roberts, M. A., Reed, J. C., Li, S., Li, X.-J. (2008). Sex-dependent Effect of BAG1 in Ameliorating Motor Deficits of Huntington Disease Transgenic Mice. J. Biol. Chem. 283: 16027-16036 [Abstract] [Full Text]  
• Wang, J., Wang, C.-E., Orr, A., Tydlacka, S., Li, S.-H., Li, X.-J. (2008). Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J. Exp. Med. 205: i9-i9 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents